image credit: Unsplash

FDA awards 11 grants for rare disease treatment developments

October 15, 2021


The US Food and Drug Administration (FDA) has awarded 11 new clinical trial research grants, equalling more than $25 million of funding over the next four years. The FDA’s Congressionally-funded Orphan Products Grants Program awards grants to clinical investigators to support the development of medical products for patients with rare diseases. The awards support clinical studies of products that address unmet needs in rare diseases or conditions or provide highly significant improvements in treatment or diagnosis.

Read More on European Pharmaceutical Review